RSS

FITX Creative Edge Nutrition Inc.

Last Post: 04/16/26
Followers: 292
Posts Today: 0
Views Today: 1338

FITX Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Sep 9, 1:19 PM EDT
Last0.0000
$ Chg0.0000
Open
High
Beta94.5194
Year High0.000
Market Cap4.6K
P/B Ratio
EPS
Avg Vol (30d)15.8K
Volume0
% Chg+0.00%
Prev Close0.0000
Low
VWAP0.00000
Year Low0.000
Total Shares
Shares Out4.63B
Float4.63B
ExchangeCV EM
Healthcare Pharmaceuticals

FITX Stock Message Board Discussion

  1. stocks-are-me
  2. Rooey
  3. fingermoney
  4. fingermoney
  5. fingermoney

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation Alerts for Spyre Therapeutics Investors Amid Concerns

Updated Category News Views 143

Investigation of Claims for Spyre Therapeutics Investors Pomerantz LLP is currently investigating claims on behalf of investors of Spyre Therapeutics, Inc. (NASDAQ: SYRE). The firm seeks to understand whether Spyre and its executives have potentially engaged in any unlawful business practices, specifically concerning securities fraud. Understanding the Securities Concerns...

Continue Reading
Natixis CIB's Pioneering Project Financing for Infrastructure

Updated Category News Views 126

Natixis CIB's Role in Groundbreaking Project Financing Natixis Corporate & Investment Banking (Natixis CIB) has taken a significant step in enhancing infrastructure development by serving as Joint Bookrunner and Joint Lead Arranger for a remarkable $281 million project financing. This financing initiative will support Ruta del Este, a concessionaire formed by ISA Vías to...

Continue Reading
Finch Therapeutics Moves to Delist from Nasdaq Amid Challenges

Updated Category News Views 177

Finch Therapeutics Plans Delisting from Nasdaq Finch Therapeutics Group, Inc. (Nasdaq: FNCH) has recently announced its decision to delist from The Nasdaq Stock Market, LLC. This move is part of a broader strategy aimed at navigating current market challenges and optimizing operational efficiency. The company is a leader in microbiome technology, boasting a strong...

Continue Reading
ModivCare: Exploring Recent Developments and Stockholder Rights

Updated Category News Views 269

Investigating the Latest Events Surrounding ModivCare Recent events surrounding ModivCare, Inc. have drawn considerable attention from the investor community and law firms alike. This scrutiny comes after a class action lawsuit from long-term shareholders, alleging the company's management may have misled investors about its ability to manage its financial health during a...

Continue Reading
Investors in Avantor, Inc. Urged to Act Before Key Deadline

Updated Category News Views 157

A Call to Action for Avantor, Inc. Investors Investors in Avantor, Inc. should take heed of an essential notification regarding a securities class action. As a market participant interested in Avantor, Inc. (NYSE: AVTR), your involvement could be crucial. This class action centers around stock purchases made during a specific timeframe that is intended to hold the company...

Continue Reading